1. Kim, Ga Hee, Won, Ji Eun, Byeon, Yeongseon, Han, Hee Dong, Park, Yeong-Min. . Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer. In Drug delivery, 25, 1394-1402. doi:10.1080/10717544.2018.1480672. https://pubmed.ncbi.nlm.nih.gov/29890852/
2. Xie, Zhenzhen, Sun, Songlin, Ji, Honglei, Liang, Hong, Yuan, Wei. 2023. Prenatal exposure to per- and polyfluoroalkyl substances and DNA methylation in the placenta: A prospective cohort study. In Journal of hazardous materials, 463, 132845. doi:10.1016/j.jhazmat.2023.132845. https://pubmed.ncbi.nlm.nih.gov/37898083/
3. Fu, Yu, Zhang, Xuan, Qiao, Qing. . PLXDC1 serves as a potential prognostic marker and involves in malignant progression and macrophage polarization in colon cancer. In Journal of biochemical and molecular toxicology, 38, e23832. doi:10.1002/jbt.23832. https://pubmed.ncbi.nlm.nih.gov/39267413/
4. Cheng, Guo, Zhong, Ming, Kawaguchi, Riki, Ter-Stepanian, Mariam, Sun, Hui. 2014. Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF. In eLife, 3, e05401. doi:10.7554/eLife.05401. https://pubmed.ncbi.nlm.nih.gov/25535841/
5. Gaultier, Alban, Simon, Gabriel, Niessen, Sherry, Cravatt, Benjamin F, Gonias, Steven L. 2010. LDL receptor-related protein 1 regulates the abundance of diverse cell-signaling proteins in the plasma membrane proteome. In Journal of proteome research, 9, 6689-95. doi:10.1021/pr1008288. https://pubmed.ncbi.nlm.nih.gov/20919742/
6. van Beijnum, Judy R, Petersen, Kjell, Griffioen, Arjan W. 2009. Tumor endothelium is characterized by a matrix remodeling signature. In Frontiers in bioscience (Scholar edition), 1, 216-25. doi:. https://pubmed.ncbi.nlm.nih.gov/19482697/
7. Tang, Ming-Yue, Shen, Xue, Yuan, Run-Sheng, Wen, He-Xin, Su, Fang. . Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion. In World journal of gastrointestinal oncology, 16, 2091-2112. doi:10.4251/wjgo.v16.i5.2091. https://pubmed.ncbi.nlm.nih.gov/38764846/